|Bid||2.05 x 100|
|Ask||2.52 x 900|
|Day's Range||2.32 - 2.54|
|52 Week Range||0.49 - 3.68|
|PE Ratio (TTM)||-3.28|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.75|
NORCROSS, Ga., May 15, 2017-- Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, today reported financial results for the three months ended March 31, 2017. ...
NORCROSS, Ga., May 03, 2017-- Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, today announced the launch of the Liver Line, an online community and publication ...
Investors certainly have to be happy with Galectin Therapeutics Inc (GALT) and its short term performance